Indication
Antiplatelet agents
2 clinical trials
3 products
Clinical trial
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes IIStatus: Recruiting, Estimated PCD: 2024-06-01
Product
AspirinClinical trial
Study to Evaluate the Safety of Reducing Dual Antiplatelet Therapy (DAPT) Duration to 1 Month for Patients With Acute Coronary Syndrome (ACS) After Implantation of Everolimus-eluting Cobalt-chromium StentStatus: Active (not recruiting), Estimated PCD: 2021-12-31
Product
1-months DAPTProduct
12-month DAPT